A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
NCT07337525
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Malignant Solid Tumor
Solid Tumor Cancer
Interventions
DRUG:
PLT012
Sponsor
Pilatus Biosciences Inc